---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-001153"
form_type: "8-K"
ticker: null
cik: "0001522860"
company_name: "Acutus Medical, Inc."
filed_at: "2024-01-11T23:59:59+00:00"
generated_at: "2026-06-07T00:32:22.967982+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Acutus Medical appoints Takeo Mukai as CEO; David Roman becomes consultant

## Summary
- David Roman departed as president and CEO effective Jan 7, 2024; also resigned from board.
- Takeo Mukai, formerly CFO, appointed CEO effective Jan 8, 2024, retaining CFO role.
- Mukai's base salary increased from $325,000 to $375,000; target bonus raised to 60% of base.
- Roman entered consulting agreement at $200/hour through Dec 31, 2024 to assist with transition and strategic options.
- Board size set at seven members.

## SEC filing metadata
- accession: 0001628280-24-001153
- form_type: 8-K
- cik: 0001522860
- company_name: Acutus Medical, Inc.
- filed_at: 2024-01-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522860/000162828024001153/0001628280-24-001153-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522860/000162828024001153/afib-20240107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-001153
- JSON: https://secwatch.observer/filing/0001628280-24-001153.json
- Plain text: https://secwatch.observer/filing/0001628280-24-001153.txt

## Key facts
- Executive change
  David Roman departed as President and Chief Executive Officer at Acutus Medical, Inc..
  - Action: departed
  - Role: President and Chief Executive Officer
  source text: David Roman was expected to depart from his position as president and chief executive officer of the Company, as part of the Company’s strategic realignment of resources and corporate restructuring, which departure became effective January 7, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522860/000162828024001153/0001628280-24-001153-index.htm
- Executive change
  David Roman resigned as Member of the Board of Directors at Acutus Medical, Inc..
  - Action: resigned
  - Role: Member of the Board of Directors
  source text: Mr. Roman has also resigned as a member of the Company’s board of directors effective January 7, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522860/000162828024001153/0001628280-24-001153-index.htm
- Executive change
  Takeo Mukai was appointed as Chief Executive Officer at Acutus Medical, Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: the Company’s board of directors approved the appointment of Takeo Mukai, the Company’s chief financial officer, as the Company’s chief executive officer, which appointment became effective January 8, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1522860/000162828024001153/0001628280-24-001153-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.